AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

Infosys lays off hundreds after failing internal assessments in Mysuru

Greater Bengaluru Committee proposes seven municipal corporations

Congress groomed me not to sit at home: Shivakumar